Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial Glycemia
Effect of Adding Escalating Doses of a Novel Highly Viscous Polysaccharide to Either a Liquid or a Solid Test Meal on Post Prandial Glycemia in Healthy Subjects: Determination of the Glycemic Reduction Index Potential (GRIP)
1 other identifier
interventional
20
1 country
1
Brief Summary
To determine palatability and extent to which escalating doses of a novel highly viscous polysaccharide \[NVP\] reduces postprandial glycemia when added to a liquid and a solid meal.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Apr 2006
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2006
CompletedFirst Submitted
Initial submission to the registry
December 3, 2008
CompletedFirst Posted
Study publicly available on registry
December 4, 2008
CompletedDecember 4, 2008
December 1, 2008
1 month
December 3, 2008
December 3, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
postprandial glycemia
Acute study measuring postprandial glucose levels over 2 hours
Secondary Outcomes (1)
The glucose reduction index potential (GRIP). The GRIP factor is the reduction in glycemic index units per gram of fiber.
Data analysis
Study Arms (6)
1
PLACEBO COMPARATORWhite Bread
2
PLACEBO COMPARATORWhite Bread and Margarine Control
3
PLACEBO COMPARATORGlucose drink control
4
EXPERIMENTALWhite bread and margarine or Glucose drink
5
EXPERIMENTALWhite bread and margarine or Glucose drink
6
EXPERIMENTALWhite bread and margarine or Glucose drink
Interventions
Eligibility Criteria
You may qualify if:
- healthy individuals
- years old
- BMI less than 35 kg/m2
You may not qualify if:
- Medications influencing gastrointestinal function
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Glycemic Index Laboratories, Inclead
- InovoBiologic Inc.collaborator
- Canadian Center for Functional Medicinecollaborator
Study Sites (1)
Glycemic Index Laboratories, Inc.
Toronto, Ontario, M5C 2X3, Canada
MeSH Terms
Interventions
Study Officials
- STUDY DIRECTOR
Alexandra L Jenkins, PhD, RD
Glycemic Index Laboratories, Inc
- PRINCIPAL INVESTIGATOR
Thomas MS Wolever, MD
Glycemic Index Laboratories, Inc
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
December 3, 2008
First Posted
December 4, 2008
Study Start
April 1, 2006
Primary Completion
May 1, 2006
Study Completion
August 1, 2006
Last Updated
December 4, 2008
Record last verified: 2008-12